We are live on ! Find out more
WST icon

West Pharmaceutical
WST

734 hedge funds and large institutions have $26B invested in West Pharmaceutical in 2023 Q2 according to their latest regulatory filings, with 93 funds opening new positions, 253 increasing their positions, 269 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

96% more call options, than puts

Call options by funds: $52M | Put options by funds: $26.5M

86% more first-time investments, than exits

New positions opened: 93 | Existing positions closed: 50

8% more capital invested

Capital invested by funds: $24B → $26B (+$1.94B)

6% more funds holding

Funds holding: 695 → 734 (+39)

6% less repeat investments, than reductions

Existing positions increased: 253 | Existing positions reduced: 269

1.95% less ownership

Funds ownership: 93.72% → 91.76% (-2%)

9% less funds holding in top 10

Funds holding in top 10: 11 → 10 (-1)

Holders
734
Holders Change
+39
Holders Change %
+5.61%
% of All Funds
11.52%
Holding in Top 10
10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-9.09%
% of All Funds
0.16%
New
93
Increased
253
Reduced
269
Closed
50
Calls
$52M
Puts
$26.5M
Net Calls
+$25.5M
Net Calls Change
-$10.5M

Top Buyers

1
Man Group
Man Group
United Kingdom
+$89.8M
2
JP Morgan Chase
JP Morgan Chase
New York
+$34.7M
3
AAM
Ardevora Asset Management
United Kingdom
+$34.4M
4
Prudential Financial
Prudential Financial
New Jersey
+$22.8M
5
KBC Group
KBC Group
Belgium
+$21.5M

Top Sellers

1
Neuberger Berman Group
Neuberger Berman Group
New York
-$86.6M
2
Ameriprise
Ameriprise
Minnesota
-$81.5M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$78.8M
4
ProShare Advisors
ProShare Advisors
Maryland
-$69M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$60.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Legal & General Group
26
Legal & General Group
United Kingdom
$208M -$11.3M -31,558 -5%
Goldman Sachs
27
Goldman Sachs
New York
$201M +$7.56M +21,171 +4%
Kayne Anderson Rudnick Investment Management
28
Kayne Anderson Rudnick Investment Management
California
$186M +$9.16M +25,642 +6%
ProShare Advisors
29
ProShare Advisors
Maryland
$184M -$69M -193,264 -29%
TD Asset Management
30
TD Asset Management
Ontario, Canada
$168M -$1.7M -4,756 -1%
N
31
Nuveen
North Carolina
$163M +$13.9M +38,855 +10%
Charles Schwab
32
Charles Schwab
California
$157M +$1.8M +5,037 +1%
State Farm Mutual Automobile Insurance
33
State Farm Mutual Automobile Insurance
Illinois
$148M – – –
CIP
34
Champlain Investment Partners
Vermont
$146M -$200K -560 -0.1%
Aberdeen Group
35
Aberdeen Group
United Kingdom
$146M -$5.69M -15,921 -4%
Amundi
36
Amundi
France
$143M +$10M +28,026 +8%
UBS AM
37
UBS AM
Illinois
$137M – – –
EAM
38
Eagle Asset Management
Florida
$134M +$13.2M +36,969 +12%
CAM
39
Congress Asset Management
Massachusetts
$131M -$2.77M -7,748 -2%
Royal Bank of Canada
40
Royal Bank of Canada
Ontario, Canada
$130M +$994K +2,783 +0.8%
Ameriprise
41
Ameriprise
Minnesota
$124M -$81.5M -228,253 -41%
A
42
AustralianSuper
Australia
$122M -$3.75M -10,494 -3%
Dimensional Fund Advisors
43
Dimensional Fund Advisors
Texas
$112M +$522K +1,461 +0.5%
Millennium Management
44
Millennium Management
New York
$111M +$9.89M +27,685 +11%
FPP
45
Findlay Park Partners
United Kingdom
$107M -$6.27M -17,538 -6%
IIP
46
Intermede Investment Partners
United Kingdom
$105M -$23M -64,268 -19%
Deutsche Bank
47
Deutsche Bank
Germany
$104M +$7.1M +19,881 +8%
Swiss National Bank
48
Swiss National Bank
Switzerland
$103M -$9.15M -25,600 -9%
Man Group
49
Man Group
United Kingdom
$96.2M +$89.8M +251,465 New
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$80.5M +$823K +2,305 +1%
1
2
3 4 5

WST Hedge Fund Activity: Q2 2023 in Review

734 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q2 2023, worth a combined $26B — up 8.1% from $24B a quarter earlier.

Buyers outnumbered sellers: 93 funds opened new WST positions and 50 closed out — a net gain of 43 holders — while 253 added to existing stakes and 269 trimmed.

The largest buyer was Man Group, opening a new position worth an estimated $89.8M. The largest seller was Neuberger Berman Group, cutting an estimated $86.6M.

  • 734 institutional investors held West Pharmaceutical (WST) as of Q2 2023, up from 695 in Q1 2023.
  • Funds reported $26B of West Pharmaceutical stock for Q2 2023, up 8.1% quarter-over-quarter.
  • 93 funds opened new West Pharmaceutical positions in Q2 2023 and 50 closed out, a net change of +43 holders.
  • The largest West Pharmaceutical buyer in Q2 2023 was Man Group, an estimated $89.8M added.
  • The largest West Pharmaceutical seller in Q2 2023 was Neuberger Berman Group, an estimated $86.6M sold.

Based on aggregated 13F filings for Q2 2023.